Le Lézard
Classified in: Health, Science and technology
Subject: FDA

Philips receives U.S. FDA 510(k) clearance for its Ingenia Elition MR solution


AMSTERDAM, June 5, 2018 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Ingenia Elition 3.0T MR solution and two clinical applications, Philips Compressed SENSE and 3D APT. This integrated suite of innovations enables clinicians to perform exams up to 50% faster [1], increase diagnostic confidence and improve the patient experience. The first commercial installation of the Philips Ingenia Elition in the U.S. has recently been completed at Hennepin Healthcare, a comprehensive healthcare system in Minneapolis.

"Together, the Ingenia Elition and our new clinical applications make producing high-quality images fast and easy, enabling prompt diagnosis and setting the stage for effective treatment," said Arjen Radder, Global Business Leader for MR at Philips. "We're receiving a strong positive reaction from our customers as we continue to roll out our all-new Ingenia digital MR portfolio. It's providing healthcare organizations like Hennepin Health with innovative solutions that seamlessly connect data, technology and people to drive the highest quality of care."

In today's healthcare landscape ? where reimbursements are becoming value-based and chronic conditions lead to more MR procedures and longer waiting times ? there is an ever-increasing pressure on the radiology department. Philips is responding to these challenges through the development of new systems and clinical applications that improve image quality and the patient and staff experience, as well as operational efficiency.

"To deliver fast, consistent and accurate diagnoses, our staff need to be supported with technology that gives them the ability to provide the best patient care, in an efficient and cost-effective way," said Dr. Chip Truwit, MD, Chair, Radiology, Hennepin Healthcare. "Philips' Ingenia Elition plays a critical role in elevating the standard of care for our patients in imaging and in improving overall operations in our new imaging center."

Improving diagnostic confidence and the patient experience
Philips Ingenia Elition and the entire digital MR portfolio empower a faster, smarter and simpler path to diagnosis ? providing patients and radiologists with the following benefits:

All-new Ingenia digital MR portfolio

The Ingenia Elition is part of Philips' all-new Ingenia digital MR portfolio, which supports radiology departments to enhance productivity, improving the patient and staff experience, while delivering better value-based care through improved patient outcomes at lower costs. In addition to receiving U.S. FDA approval the Ingenia Elition 3.0T is also available for sale in Europe.

[1] Using Compressed SENSE technology and compared to Philips exams without Compressed SENSE
[2] SmartExam is not available to patients with MR Conditional implants
[3] Togao et al. (2014) Neuro-Oncology
[4] Park KJ et al. (2016) European Radiology
[5] Results from case studies are not predictive of results in other cases. Results in other cases may vary
[6] Compared to the average of the other five Philips MR scanners without Ambient Experience and In-bore Connect. Results from case studies are not predictive of results in other studies. Results in other cases may vary
[7] Based on in-house testing

For further information, please contact:

Mark Groves
Philips Group Press Office
Tel.: +31 631 639 916
E-mail: [email protected] 

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.

Royal Philips. (PRNewsFoto/Royal Philips)

SOURCE Royal Philips


These press releases may also interest you

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:00
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...

at 10:00
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...

at 10:00
NastLaw LLC announces: If you purchased certain named generic pharmaceutical drugs directly from certain pharmaceutical manufacturers from May 1, 2009 through December 31, 2019, your rights may be affected by proposed class action settlements.A...

at 09:48
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...

at 09:38
The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative. The award recognized Pfizer's atopic dermatitis interactive guide for varying skin tones....



News published on and distributed by: